Biopharmaceutical network
Biopharmaceutical Network (BioPharmNet.com)
is a nonprofit professional organization aimed at promoting collaboration,
novel scientific solutions and knowledge sharing in biopharmaceutical
drug development.
Mission
Facilitate discussion and collaboration.
Bring stakeholders from the industry, academia and regulatory
agencies to a virtual table to facilitate the discussion of key
issues in drug development with emphasis on underlying science
and novel methodologies.
Manage knowledge. Build a central information resource
for scientists involved in drug development to help create and
leverage knowledge across the biopharmaceutical industry.
Executive Committee
Biopharmaceutical Network is run by its executive
committee.
Christy Chuang-Stein, Ph.D.
|
Executive Director
Pfizer Global Research and Development
Bio
sketch |
Ralph D'Agostino, Sr., Ph.D.
|
Professor of Mathematics/Statistics
and Public Health
Boston University
Bio
sketch |
Alex Dmitrienko, Ph.D.
|
Research Advisor
Global Statistics
Eli Lilly and Company
Bio
sketch |
Gregory Enas, Ph.D.
Director
Regulatory Affairs
Eli Lilly and Company
Michael Krams, M.D.
Assistant Vice President
Adaptive Trials, Clinical Development
Wyeth Pharmaceuticals
Scott Patterson, Ph.D.
|
Senior Director, Vaccines and Infectious
Disease
Wyeth Research and Development
Bio
sketch |
José Pinheiro, Ph.D.
|
Director of Biostatistics
Clinical Development and Medical Affairs
Novartis Pharmaceuticals
Bio
sketch |
Frank Shen, Ph.D.
|
Head of Biometrics
Shanghai Roche Pharmaceuticals
Bio
sketch |
Brian Wiens, Ph.D.
|
|
 |
